The "The FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ResearchAndMarkets.com's offering.

The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...

Indian pharmaceutical companies are gaining ground in the Chinese market, winning bids to supply bulk generic drugs, including Dapagliflozin for diabetes treatment. Hetero Labs Limited, Cipla Ltd, ...

India is the largest supplier of generic drugs globally. Indian pharmaceutical companies supply nearly 50% of all generic ...

Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive ...

On October 29, 2025, the U.S. Food and Drug Administration (FDA), in coordination with the Department of Health and Human Services (HHS) and ...

The European Commission’s plan to use joint procurement to provide access to innovative drugs across the bloc risks overuse ...

The "Pharmaceutical Dissolution Market - A Global and Regional Analysis: Focus on Type, End User, and Region - Analysis and Forecast, 2024-2033" has been added to ResearchAndMarkets.com's offering.

The FDA's recall pertains to several lots of lisdexamfetamine dimesylate capsules that failed to meet essential dissolution tests. Dissolution is a crucial process in pharmacology that determines how ...

This case study demonstrates how advanced NMR spectroscopy enables high-resolution structural characterization of exenatide.

Following the release on the 14th of the **‘Joint Fact Sheet, the Joint Explanatory Document’**, which outlines the results ...